NIO's chip subsidiary raised over 2.2 billion in its first round of financing: with a valuation of nearly 10 billion, top institutions such as Hefei State Investment, IDG, and SMIC Ventures participated.
NIO's chip subsidiary receives over 2.2 billion yuan in Series A financing.
On February 26, NIO announced that its chip subsidiary, Anhui Shenji Technology Co., Ltd., has completed the signing of a first-round equity financing agreement, with a financing amount exceeding 2.2 billion RMB and a post-investment valuation of nearly 10 billion RMB. This round of financing has attracted investment from multiple industry capital and industry leading institutions such as Hefei Guotou, Hefei Haiheng, IDG Capital, SMIC Polytron, and Yuanhe Puhua. This financing will help Shenji Company continue to research and promote high-end, competitive chip products, supporting NIO's long-term layout in the fields of autonomous driving and embodied intelligence.
Anhui Shenji is the first company in China to research and develop 5nm vehicle-grade chips, and the first company to achieve large-scale commercial use. The performance of Shenji NX9031 chip, which "equals four chips in one," has always been at the forefront of domestic automotive chips. Since its production in 2024, it has accumulated shipments of over 150,000 sets, successfully deployed in all models of the NIO brand. After this round of financing, Shenji Company will also launch ultra-powerful performance chips for the next generation of intelligent driving and multiple chips for other areas. Shenji Company's previous orders mainly came from NIO, while also actively expanding into emerging businesses such as Siasun Robot&Automation, and Agent reasoning, providing complete chip and intelligent hardware solutions to various customers in the AGI era.
Related Articles

OSHIDORI (00622) issued 760 million shares in accordance with the share exchange agreement.

JNBY (03306) will distribute a mid-year dividend of HK$0.52 per share on April 15th.

BEONE MEDICINES (06160) expects strong growth in performance in 2025, with adjusted net profit of approximately 918 million US dollars, turning losses into profits year-on-year.
OSHIDORI (00622) issued 760 million shares in accordance with the share exchange agreement.

JNBY (03306) will distribute a mid-year dividend of HK$0.52 per share on April 15th.

BEONE MEDICINES (06160) expects strong growth in performance in 2025, with adjusted net profit of approximately 918 million US dollars, turning losses into profits year-on-year.

RECOMMEND

Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026

Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026

AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026


